Applying the principles of stem-cell biology to cancer

被引：1244
作者：
Pardal, R
Clarke, MF
Morrison, SJ
机构：
[1] Univ Michigan, Howard Hughes Med Inst, CCGC 3215, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Internal Med, CCGC 3215, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Dept Cell & Dev Biol, CCGC 3215, Ann Arbor, MI 48109 USA
[4] Univ Michigan, Dept Internal Med, CCGC 4310, Ann Arbor, MI 48109 USA
[5] Univ Michigan, Dept Cell & Dev Biol, CCGC 4310, Ann Arbor, MI 48109 USA
来源：
NATURE REVIEWS CANCER | 2003年 / 3卷 / 12期
关键词：
D O I：
10.1038/nrc1232
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Why are tumours heterogeneous, in terms of cell phenotype and proliferative potential, even in cases in which all cells are derived from a single clone? Ongoing mutagenesis can partially explain this heterogeneity, but it also seems that some tumours arise from small populations of 'cancer stem cells' that give rise to phenotypically diverse cancer cells, with less proliferative potential. These cancer stem cells are likely to arise from mutations that dysregulate normal stem-cell self-renewal. Using this information, it might be possible to devise more effective therapies.
引用
收藏
页码：895 / 902
页数：8
相关论文
共 103 条
[81]  
Singh SK, 2003, CANCER RES, V63, P5821
[82]   Sonic hedgehog signaling is essential for hair development [J].
St-Jacques, B ;
Dassule, HR ;
Karavanova, I ;
Botchkarev, VA ;
Li, J ;
Danielian, PS ;
McMahon, JA ;
Lewis, PM ;
Paus, R ;
McMahon, AP .
CURRENT BIOLOGY, 1998, 8 (19) :1058-1068
[83]   EVALUATION OF REPRODUCTIVE CAPACITY IN GERM-CELL TUMOR PATIENTS FOLLOWING TREATMENT WITH CISPLATIN, ETOPOSIDE, AND BLEOMYCIN [J].
STEPHENSON, WT ;
POIRIER, SM ;
RUBIN, L ;
EINHORN, LH .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (09) :2278-2280
[84]   The Hedgehog and Wnt signaling pathways in cancer [J].
Taipale, J ;
Beachy, PA .
NATURE, 2001, 411 (6835) :349-354
[85]   Mutations in SUFU predispose to medulloblastoma [J].
Taylor, MD ;
Liu, L ;
Raffel, C ;
Hui, CC ;
Mainprize, TG ;
Zhang, XY ;
Agatep, R ;
Chiappa, S ;
Gao, LZ ;
Lowrance, A ;
Hao, AH ;
Goldstein, AM ;
Stavrou, T ;
Scherer, SW ;
Dura, WT ;
Wainwright, B ;
Squire, JA ;
Rutka, JT ;
Hogg, D .
NATURE GENETICS, 2002, 31 (03) :306-310
[86]   TUMOR STEM-CELLS - THE BIOLOGICAL CONCEPT AND ITS APPLICATION IN CANCER-TREATMENT [J].
TROTT, KR .
RADIOTHERAPY AND ONCOLOGY, 1994, 30 (01) :1-5
[87]   The β-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells [J].
van de Wetering, M ;
Sancho, E ;
Verweij, C ;
de Lau, W ;
Oving, I ;
Hurlstone, A ;
van der Horn, K ;
Batlle, E ;
Coudreuse, D ;
Haramis, AP ;
Tion-Pon-Fong, M ;
Moerer, P ;
van den Born, M ;
Soete, G ;
Pals, S ;
Eilers, M ;
Medema, R ;
Clevers, H .
CELL, 2002, 111 (02) :241-250
[88]   Role of members of the Wnt gene family in human hematopoiesis [J].
Van den Berg, DJ ;
Sharma, AK ;
Bruno, E ;
Hoffman, R .
BLOOD, 1998, 92 (09) :3189-3202
[89]   Coexpression of BMI-1 and EZH2 polycomb-group proteins is associated with cycling cells and degree of malignancy in B-cell non-Hodgkin lymphoma [J].
van Kemenade, FJ ;
Raaphorst, FM ;
Blokzijl, T ;
Fieret, E ;
Hamer, KM ;
Satijn, DPE ;
Otte, AP ;
Meijer, CJLM .
BLOOD, 2001, 97 (12) :3896-3901
[90]   POSTERIOR TRANSFORMATION, NEUROLOGICAL ABNORMALITIES, AND SEVERE HEMATOPOIETIC DEFECTS IN MICE WITH A TARGETED DELETION OF THE BMI-1 PROTOONCOGENE [J].
VANDERLUGT, NMT ;
DOMEN, J ;
LINDERS, K ;
VANROON, M ;
ROBANUSMAANDAG, E ;
TERIELE, H ;
VANDERVALK, M ;
DESCHAMPS, J ;
SOFRONIEW, M ;
VANLOHUIZEN, M ;
BERNS, A .
GENES & DEVELOPMENT, 1994, 8 (07) :757-769
234567891011